| |
| Magyar Angiológiai és Érsebészeti Társaság |
|
| Gloviczki Péter Professzor díszdoktorrá avatása (Budapest, Semmelweis Egyetem, 2014. 11.14.) |
 Rendezvény kezdete: 2014.11.14. | Rendezvény vége: 2014.11.14. |
| Helyszín: Budapest, Üllői út 26., Semmelweis Szalon |
Tisztelettel meghívjuk Önöket Gloviczki Péter Professzor úr díszdoktorrá avatására.
Helyszín: Semmelweis Egyetem Központi Épülete, Semmelweis Szalon (Budapest, VIII. Üllői út 26.)
Időpont: 2014. 11.14.
Program:
10.00
Procession of the awardees and the University leaders Hungarian National Anthem
10.05 Dr. Ágoston Szél, Rector of Semmelweis University welcomes the guests and opens the ceremony
10.10 Laudations of the Doctor Honoris Causa awardees
Dr. Herbert EHRINGER
Dr. Péter GLOVICZKI
Dr. René Sylvain KAHN
Dr. Richard M. SATAVA
10.25 Presentation of the Doctor Honoris Causa awards
10.30
Addresses by the newly awarded Honorary Doctors
10.40 Musical Performance
10.45 Rector Ágoston Szél closes the ceremony
Exit procession of the University leaders and awardees
Hungarian National Song: Szózat (“Summons”)
11.00
Reception at the Hall |
|
|
 |
| |
| Magyar Immunológiai Társaság |
|
| 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) |
| Rendezvény kezdete: 2011.05.19. | Rendezvény vége: 2011.05.22. |
| Helyszín: Spain / Spanyolország, Barcelona, Palau de Congressos de Catalunya |
| A rendezvény Web oldala: http://www.comtecmed.com/chep/2011/ |
Dear Friends and Colleagues,
The field of Viral Hepatitis is experiencing vast expansion in clinical trials and basic research, as well as in emerging cutting-edge technology. Exciting new drugs are soon becoming available.
The 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) will function as a comprehensive forum where international experts share and debate state-of-the-art management issues, such as appropriate use of new drugs, in order to outline the optimal treatment for patients.
This innovative Congress is unique in its explicit focus on resolving controversies related to clinical management and treatment of patients infected with viral hepatitis. Controversies raised by recent advances in Hepatitis care will be addressed throughout the comprehensive meeting.
Participants will have the advantage of discussing and debating these unresolved issues with leading world experts in all fields of Viral Hepatitis. Allowing ample time for speaker-audience discussion, the Congress aims at reaching up-to-date and agreed-upon answers to ongoing debates, even when data remains limited, through evidence-based medicine and expert opinion.
We invite you to take part in the 1st C-Hep Congress which is intended as the inaugural event of annual future editions.
We look forward to an exciting academic event in the beautiful city of Barcelona.
Sincerely,
Jürgen Rockstroh MD, Jonathan M. Schapiro MD
Co-Chairpersons
|
|
|
|
